High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.

[1]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Amy M. Sitapati,et al.  Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  L. Mariani,et al.  Soft tissue sarcoma nomograms and their incorporation into practice , 2017, Cancer.

[4]  J. Blay,et al.  Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. , 2017, The Lancet. Oncology.

[5]  A. Gronchi,et al.  Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications , 2017, Therapeutic advances in medical oncology.

[6]  R. Benjamin.  Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomas: A Personal Point of View , 2017, Tumori.

[7]  A. Llombart‐Bosch,et al.  Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  E. Sausville,et al.  Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas , 2016, Cancer Chemotherapy and Pharmacology.

[9]  L. Mariani,et al.  Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. , 2016, The Lancet. Oncology.

[10]  C. Antonescu,et al.  Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma , 2014, Annals of surgery.

[11]  A. Llombart‐Bosch,et al.  Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy , 2012, Cancer.

[12]  J. Verweij,et al.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[13]  A. D. Dei Tos,et al.  Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  V. Torri,et al.  High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. , 2009, Radiology.

[15]  F. Farrokhyar,et al.  A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.

[16]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Haesun Choi,et al.  We should desist using RECIST, at least in GIST. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Haesun Choi,et al.  Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Kattan,et al.  Postoperative nomogram for 12-year sarcoma-specific death. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J W Oosterhuis,et al.  A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. , 2001, European journal of cancer.

[21]  E Marubini,et al.  Analysing Survival Data from Clinical Trials and Observational Studies; E. Marubini & M. G. Valsecchi Published by John Wiley & Sons 414 pages ISBN 0-971-93987-0. , 1995, British journal of clinical pharmacology.

[22]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  Robin L. Jones,et al.  Treatment of soft tissue sarcoma: a focus on earlier stages. , 2017, Future oncology.

[25]  P. Casali.  Adjuvant chemotherapy for soft tissue sarcoma. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[26]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[27]  D. Cox.  Regression Models and Life-Tables , 1972 .